nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Dactinomycin—sarcoma	0.113	0.289	CbGbCtD
Terazosin—ABCB1—Mitoxantrone—sarcoma	0.101	0.259	CbGbCtD
Terazosin—ABCB1—Vincristine—sarcoma	0.0695	0.178	CbGbCtD
Terazosin—ABCB1—Etoposide—sarcoma	0.0637	0.163	CbGbCtD
Terazosin—ABCB1—Doxorubicin—sarcoma	0.0434	0.111	CbGbCtD
Terazosin—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00157	0.00258	CcSEcCtD
Terazosin—Cardiac failure—Doxorubicin—sarcoma	0.00156	0.00256	CcSEcCtD
Terazosin—Paraesthesia—Mitoxantrone—sarcoma	0.00156	0.00256	CcSEcCtD
Terazosin—Loss of consciousness—Etoposide—sarcoma	0.00156	0.00255	CcSEcCtD
Terazosin—Cerebrovascular accident—Doxorubicin—sarcoma	0.00156	0.00255	CcSEcCtD
Terazosin—Decreased appetite—Vincristine—sarcoma	0.00155	0.00254	CcSEcCtD
Terazosin—Dyspnoea—Mitoxantrone—sarcoma	0.00155	0.00254	CcSEcCtD
Terazosin—Cough—Etoposide—sarcoma	0.00154	0.00253	CcSEcCtD
Terazosin—Somnolence—Mitoxantrone—sarcoma	0.00154	0.00253	CcSEcCtD
Terazosin—Fatigue—Vincristine—sarcoma	0.00154	0.00252	CcSEcCtD
Terazosin—Convulsion—Etoposide—sarcoma	0.00153	0.00251	CcSEcCtD
Terazosin—Dyspepsia—Mitoxantrone—sarcoma	0.00153	0.00251	CcSEcCtD
Terazosin—Pain—Vincristine—sarcoma	0.00152	0.0025	CcSEcCtD
Terazosin—Constipation—Vincristine—sarcoma	0.00152	0.0025	CcSEcCtD
Terazosin—Pain in extremity—Doxorubicin—sarcoma	0.00152	0.0025	CcSEcCtD
Terazosin—Osteoarthritis—Doxorubicin—sarcoma	0.00152	0.0025	CcSEcCtD
Terazosin—Decreased appetite—Mitoxantrone—sarcoma	0.00151	0.00248	CcSEcCtD
Terazosin—Chest pain—Etoposide—sarcoma	0.00151	0.00247	CcSEcCtD
Terazosin—Orthostatic hypotension—Epirubicin—sarcoma	0.0015	0.00247	CcSEcCtD
Terazosin—Migraine—Doxorubicin—sarcoma	0.0015	0.00246	CcSEcCtD
Terazosin—Hypokalaemia—Epirubicin—sarcoma	0.0015	0.00246	CcSEcCtD
Terazosin—Fatigue—Mitoxantrone—sarcoma	0.0015	0.00246	CcSEcCtD
Terazosin—Discomfort—Etoposide—sarcoma	0.00149	0.00244	CcSEcCtD
Terazosin—Constipation—Mitoxantrone—sarcoma	0.00149	0.00244	CcSEcCtD
Terazosin—Pain—Mitoxantrone—sarcoma	0.00149	0.00244	CcSEcCtD
Terazosin—Hypersensitivity—Thiotepa—sarcoma	0.00148	0.00243	CcSEcCtD
Terazosin—Nasopharyngitis—Epirubicin—sarcoma	0.00147	0.00242	CcSEcCtD
Terazosin—Face oedema—Doxorubicin—sarcoma	0.00147	0.00241	CcSEcCtD
Terazosin—Hypersensitivity—Dactinomycin—sarcoma	0.00147	0.00241	CcSEcCtD
Terazosin—Gastrointestinal pain—Vincristine—sarcoma	0.00146	0.00239	CcSEcCtD
Terazosin—Gastritis—Epirubicin—sarcoma	0.00146	0.00239	CcSEcCtD
Terazosin—Confusional state—Etoposide—sarcoma	0.00146	0.00239	CcSEcCtD
Terazosin—Anaphylactic shock—Etoposide—sarcoma	0.00144	0.00237	CcSEcCtD
Terazosin—Asthenia—Thiotepa—sarcoma	0.00144	0.00237	CcSEcCtD
Terazosin—Asthenia—Dactinomycin—sarcoma	0.00143	0.00235	CcSEcCtD
Terazosin—Feeling abnormal—Mitoxantrone—sarcoma	0.00143	0.00235	CcSEcCtD
Terazosin—Asthma—Epirubicin—sarcoma	0.00142	0.00234	CcSEcCtD
Terazosin—Influenza—Epirubicin—sarcoma	0.00142	0.00234	CcSEcCtD
Terazosin—Pruritus—Thiotepa—sarcoma	0.00142	0.00233	CcSEcCtD
Terazosin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00142	0.00233	CcSEcCtD
Terazosin—Thrombocytopenia—Etoposide—sarcoma	0.00141	0.00232	CcSEcCtD
Terazosin—Tachycardia—Etoposide—sarcoma	0.00141	0.00231	CcSEcCtD
Terazosin—Abdominal pain—Vincristine—sarcoma	0.00141	0.00231	CcSEcCtD
Terazosin—Body temperature increased—Vincristine—sarcoma	0.00141	0.00231	CcSEcCtD
Terazosin—Hyperhidrosis—Etoposide—sarcoma	0.0014	0.00229	CcSEcCtD
Terazosin—Orthostatic hypotension—Doxorubicin—sarcoma	0.00139	0.00228	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—sarcoma	0.00139	0.00228	CcSEcCtD
Terazosin—Angina pectoris—Epirubicin—sarcoma	0.00139	0.00227	CcSEcCtD
Terazosin—Anorexia—Etoposide—sarcoma	0.00138	0.00226	CcSEcCtD
Terazosin—Diarrhoea—Thiotepa—sarcoma	0.00138	0.00226	CcSEcCtD
Terazosin—Body temperature increased—Mitoxantrone—sarcoma	0.00137	0.00225	CcSEcCtD
Terazosin—Abdominal pain—Mitoxantrone—sarcoma	0.00137	0.00225	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—sarcoma	0.00137	0.00225	CcSEcCtD
Terazosin—Diarrhoea—Dactinomycin—sarcoma	0.00137	0.00224	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—sarcoma	0.00136	0.00224	CcSEcCtD
Terazosin—Hypotension—Etoposide—sarcoma	0.00135	0.00221	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—sarcoma	0.00135	0.00221	CcSEcCtD
Terazosin—Dysuria—Epirubicin—sarcoma	0.00133	0.00218	CcSEcCtD
Terazosin—Dizziness—Thiotepa—sarcoma	0.00133	0.00218	CcSEcCtD
Terazosin—Asthma—Doxorubicin—sarcoma	0.00132	0.00216	CcSEcCtD
Terazosin—Influenza—Doxorubicin—sarcoma	0.00132	0.00216	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—sarcoma	0.00132	0.00216	CcSEcCtD
Terazosin—Hypersensitivity—Vincristine—sarcoma	0.00131	0.00215	CcSEcCtD
Terazosin—Photosensitivity reaction—Epirubicin—sarcoma	0.0013	0.00213	CcSEcCtD
Terazosin—Paraesthesia—Etoposide—sarcoma	0.0013	0.00213	CcSEcCtD
Terazosin—Weight increased—Epirubicin—sarcoma	0.0013	0.00213	CcSEcCtD
Terazosin—Dyspnoea—Etoposide—sarcoma	0.00129	0.00211	CcSEcCtD
Terazosin—Somnolence—Etoposide—sarcoma	0.00128	0.00211	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—sarcoma	0.00128	0.0021	CcSEcCtD
Terazosin—Hypersensitivity—Mitoxantrone—sarcoma	0.00128	0.0021	CcSEcCtD
Terazosin—Asthenia—Vincristine—sarcoma	0.00128	0.0021	CcSEcCtD
Terazosin—Vomiting—Thiotepa—sarcoma	0.00128	0.0021	CcSEcCtD
Terazosin—Vomiting—Dactinomycin—sarcoma	0.00127	0.00208	CcSEcCtD
Terazosin—Rash—Thiotepa—sarcoma	0.00127	0.00208	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—sarcoma	0.00127	0.00208	CcSEcCtD
Terazosin—Dermatitis—Thiotepa—sarcoma	0.00127	0.00208	CcSEcCtD
Terazosin—Headache—Thiotepa—sarcoma	0.00126	0.00207	CcSEcCtD
Terazosin—Rash—Dactinomycin—sarcoma	0.00126	0.00206	CcSEcCtD
Terazosin—Decreased appetite—Etoposide—sarcoma	0.00126	0.00206	CcSEcCtD
Terazosin—Asthenia—Mitoxantrone—sarcoma	0.00125	0.00204	CcSEcCtD
Terazosin—Fatigue—Etoposide—sarcoma	0.00125	0.00204	CcSEcCtD
Terazosin—Jaundice—Epirubicin—sarcoma	0.00124	0.00203	CcSEcCtD
Terazosin—Constipation—Etoposide—sarcoma	0.00124	0.00203	CcSEcCtD
Terazosin—Pain—Etoposide—sarcoma	0.00124	0.00203	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—sarcoma	0.00123	0.00202	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—sarcoma	0.00123	0.00202	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—sarcoma	0.00123	0.00202	CcSEcCtD
Terazosin—Diarrhoea—Vincristine—sarcoma	0.00122	0.002	CcSEcCtD
Terazosin—Sweating—Epirubicin—sarcoma	0.00122	0.002	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—sarcoma	0.00122	0.002	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—sarcoma	0.0012	0.00197	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—sarcoma	0.0012	0.00197	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—sarcoma	0.0012	0.00196	CcSEcCtD
Terazosin—Nausea—Thiotepa—sarcoma	0.00119	0.00196	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—sarcoma	0.00119	0.00195	CcSEcCtD
Terazosin—Feeling abnormal—Etoposide—sarcoma	0.00119	0.00195	CcSEcCtD
Terazosin—Diarrhoea—Mitoxantrone—sarcoma	0.00119	0.00195	CcSEcCtD
Terazosin—Nausea—Dactinomycin—sarcoma	0.00119	0.00194	CcSEcCtD
Terazosin—Gastrointestinal pain—Etoposide—sarcoma	0.00118	0.00194	CcSEcCtD
Terazosin—Dizziness—Vincristine—sarcoma	0.00118	0.00193	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—sarcoma	0.00115	0.00188	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—sarcoma	0.00114	0.00187	CcSEcCtD
Terazosin—Body temperature increased—Etoposide—sarcoma	0.00114	0.00187	CcSEcCtD
Terazosin—Abdominal pain—Etoposide—sarcoma	0.00114	0.00187	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—sarcoma	0.00114	0.00187	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—sarcoma	0.00114	0.00187	CcSEcCtD
Terazosin—Vomiting—Vincristine—sarcoma	0.00113	0.00186	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—sarcoma	0.00113	0.00185	CcSEcCtD
Terazosin—Sweating—Doxorubicin—sarcoma	0.00113	0.00185	CcSEcCtD
Terazosin—Rash—Vincristine—sarcoma	0.00112	0.00184	CcSEcCtD
Terazosin—Dermatitis—Vincristine—sarcoma	0.00112	0.00184	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—sarcoma	0.00112	0.00184	CcSEcCtD
Terazosin—Headache—Vincristine—sarcoma	0.00112	0.00183	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—sarcoma	0.00111	0.00182	CcSEcCtD
Terazosin—Vomiting—Mitoxantrone—sarcoma	0.0011	0.00181	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—sarcoma	0.0011	0.00181	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—sarcoma	0.0011	0.0018	CcSEcCtD
Terazosin—Rash—Mitoxantrone—sarcoma	0.00109	0.0018	CcSEcCtD
Terazosin—Dermatitis—Mitoxantrone—sarcoma	0.00109	0.00179	CcSEcCtD
Terazosin—Headache—Mitoxantrone—sarcoma	0.00109	0.00178	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—sarcoma	0.00107	0.00175	CcSEcCtD
Terazosin—Hypersensitivity—Etoposide—sarcoma	0.00106	0.00175	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—sarcoma	0.00106	0.00174	CcSEcCtD
Terazosin—Nausea—Vincristine—sarcoma	0.00106	0.00174	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—sarcoma	0.00106	0.00173	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—sarcoma	0.00105	0.00172	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—sarcoma	0.00104	0.0017	CcSEcCtD
Terazosin—Asthenia—Etoposide—sarcoma	0.00104	0.0017	CcSEcCtD
Terazosin—Nausea—Mitoxantrone—sarcoma	0.00103	0.00169	CcSEcCtD
Terazosin—Pruritus—Etoposide—sarcoma	0.00102	0.00168	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—sarcoma	0.00102	0.00167	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—sarcoma	0.00102	0.00167	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—sarcoma	0.000992	0.00163	CcSEcCtD
Terazosin—Diarrhoea—Etoposide—sarcoma	0.000988	0.00162	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—sarcoma	0.000985	0.00162	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—sarcoma	0.000983	0.00161	CcSEcCtD
Terazosin—Flatulence—Epirubicin—sarcoma	0.000978	0.0016	CcSEcCtD
Terazosin—Tension—Epirubicin—sarcoma	0.000974	0.0016	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—sarcoma	0.000972	0.00159	CcSEcCtD
Terazosin—Nervousness—Epirubicin—sarcoma	0.000964	0.00158	CcSEcCtD
Terazosin—Back pain—Epirubicin—sarcoma	0.00096	0.00157	CcSEcCtD
Terazosin—Dizziness—Etoposide—sarcoma	0.000955	0.00157	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—sarcoma	0.000942	0.00154	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—sarcoma	0.000935	0.00153	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—sarcoma	0.000921	0.00151	CcSEcCtD
Terazosin—Vomiting—Etoposide—sarcoma	0.000918	0.00151	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—sarcoma	0.000918	0.00151	CcSEcCtD
Terazosin—Rash—Etoposide—sarcoma	0.000911	0.00149	CcSEcCtD
Terazosin—Dermatitis—Etoposide—sarcoma	0.00091	0.00149	CcSEcCtD
Terazosin—Headache—Etoposide—sarcoma	0.000905	0.00148	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—sarcoma	0.000905	0.00148	CcSEcCtD
Terazosin—Tension—Doxorubicin—sarcoma	0.000901	0.00148	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—sarcoma	0.000899	0.00147	CcSEcCtD
Terazosin—Malaise—Epirubicin—sarcoma	0.000895	0.00147	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—sarcoma	0.000892	0.00146	CcSEcCtD
Terazosin—Vertigo—Epirubicin—sarcoma	0.000891	0.00146	CcSEcCtD
Terazosin—Syncope—Epirubicin—sarcoma	0.00089	0.00146	CcSEcCtD
Terazosin—Back pain—Doxorubicin—sarcoma	0.000888	0.00146	CcSEcCtD
Terazosin—Palpitations—Epirubicin—sarcoma	0.000877	0.00144	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—sarcoma	0.000872	0.00143	CcSEcCtD
Terazosin—Cough—Epirubicin—sarcoma	0.000866	0.00142	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—sarcoma	0.000865	0.00142	CcSEcCtD
Terazosin—Convulsion—Epirubicin—sarcoma	0.00086	0.00141	CcSEcCtD
Terazosin—Nausea—Etoposide—sarcoma	0.000858	0.00141	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—sarcoma	0.000852	0.0014	CcSEcCtD
Terazosin—Chest pain—Epirubicin—sarcoma	0.000845	0.00139	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—sarcoma	0.000845	0.00139	CcSEcCtD
Terazosin—Myalgia—Epirubicin—sarcoma	0.000845	0.00139	CcSEcCtD
Terazosin—Anxiety—Epirubicin—sarcoma	0.000842	0.00138	CcSEcCtD
Terazosin—Discomfort—Epirubicin—sarcoma	0.000835	0.00137	CcSEcCtD
Terazosin—Malaise—Doxorubicin—sarcoma	0.000828	0.00136	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—sarcoma	0.000826	0.00135	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—sarcoma	0.000825	0.00135	CcSEcCtD
Terazosin—Syncope—Doxorubicin—sarcoma	0.000823	0.00135	CcSEcCtD
Terazosin—Confusional state—Epirubicin—sarcoma	0.000816	0.00134	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—sarcoma	0.000811	0.00133	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—sarcoma	0.00081	0.00133	CcSEcCtD
Terazosin—Oedema—Epirubicin—sarcoma	0.00081	0.00133	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—sarcoma	0.000807	0.00132	CcSEcCtD
Terazosin—Cough—Doxorubicin—sarcoma	0.000801	0.00131	CcSEcCtD
Terazosin—Shock—Epirubicin—sarcoma	0.000797	0.00131	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—sarcoma	0.000795	0.0013	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—sarcoma	0.000793	0.0013	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—sarcoma	0.00079	0.0013	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—sarcoma	0.000783	0.00128	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—sarcoma	0.000782	0.00128	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—sarcoma	0.000782	0.00128	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—sarcoma	0.000782	0.00128	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—sarcoma	0.000779	0.00128	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—sarcoma	0.000772	0.00127	CcSEcCtD
Terazosin—Anorexia—Epirubicin—sarcoma	0.000772	0.00127	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—sarcoma	0.000764	0.00125	CcSEcCtD
Terazosin—Hypotension—Epirubicin—sarcoma	0.000757	0.00124	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—sarcoma	0.000755	0.00124	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—sarcoma	0.000749	0.00123	CcSEcCtD
Terazosin—Oedema—Doxorubicin—sarcoma	0.000749	0.00123	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000738	0.00121	CcSEcCtD
Terazosin—Shock—Doxorubicin—sarcoma	0.000737	0.00121	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—sarcoma	0.000734	0.0012	CcSEcCtD
Terazosin—Insomnia—Epirubicin—sarcoma	0.000732	0.0012	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—sarcoma	0.000731	0.0012	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—sarcoma	0.000727	0.00119	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—sarcoma	0.000724	0.00119	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—sarcoma	0.000722	0.00118	CcSEcCtD
Terazosin—Somnolence—Epirubicin—sarcoma	0.00072	0.00118	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—sarcoma	0.000714	0.00117	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—sarcoma	0.000713	0.00117	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—sarcoma	0.000704	0.00115	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—sarcoma	0.0007	0.00115	CcSEcCtD
Terazosin—Fatigue—Epirubicin—sarcoma	0.000698	0.00114	CcSEcCtD
Terazosin—Pain—Epirubicin—sarcoma	0.000692	0.00114	CcSEcCtD
Terazosin—Constipation—Epirubicin—sarcoma	0.000692	0.00114	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000683	0.00112	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—sarcoma	0.000678	0.00111	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—sarcoma	0.000673	0.0011	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—sarcoma	0.000668	0.0011	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—sarcoma	0.000667	0.00109	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—sarcoma	0.000666	0.00109	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—sarcoma	0.000662	0.00109	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—sarcoma	0.000659	0.00108	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—sarcoma	0.000651	0.00107	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—sarcoma	0.000646	0.00106	CcSEcCtD
Terazosin—Pain—Doxorubicin—sarcoma	0.000641	0.00105	CcSEcCtD
Terazosin—Constipation—Doxorubicin—sarcoma	0.000641	0.00105	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—sarcoma	0.00064	0.00105	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—sarcoma	0.00064	0.00105	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—sarcoma	0.000617	0.00101	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000613	0.001	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—sarcoma	0.000597	0.000978	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—sarcoma	0.000592	0.000971	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—sarcoma	0.000592	0.000971	CcSEcCtD
Terazosin—Asthenia—Epirubicin—sarcoma	0.000581	0.000953	CcSEcCtD
Terazosin—Pruritus—Epirubicin—sarcoma	0.000573	0.000939	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—sarcoma	0.000554	0.000909	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—sarcoma	0.000552	0.000905	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—sarcoma	0.000538	0.000882	CcSEcCtD
Terazosin—Dizziness—Epirubicin—sarcoma	0.000535	0.000878	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—sarcoma	0.00053	0.000869	CcSEcCtD
Terazosin—Vomiting—Epirubicin—sarcoma	0.000515	0.000844	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—sarcoma	0.000513	0.000841	CcSEcCtD
Terazosin—Rash—Epirubicin—sarcoma	0.000511	0.000837	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—sarcoma	0.00051	0.000836	CcSEcCtD
Terazosin—Headache—Epirubicin—sarcoma	0.000507	0.000832	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—sarcoma	0.000495	0.000812	CcSEcCtD
Terazosin—Nausea—Epirubicin—sarcoma	0.000481	0.000789	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—sarcoma	0.000476	0.000781	CcSEcCtD
Terazosin—Rash—Doxorubicin—sarcoma	0.000472	0.000775	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—sarcoma	0.000472	0.000774	CcSEcCtD
Terazosin—Headache—Doxorubicin—sarcoma	0.000469	0.00077	CcSEcCtD
Terazosin—Nausea—Doxorubicin—sarcoma	0.000445	0.00073	CcSEcCtD
